MedPath

medac Gesellschaft für klinische Spezialpräparate mbH

🇩🇪Germany
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.medac.de

Clinical Trials

20

Active:18
Completed:1

Trial Phases

1 Phases

Phase 1:11

Drug Approvals

33

EMA:9
CIMA_AEMPS:9
NMPA:8
+1 more agencies

Drug Approvals

Methotrexate Injection

Product Name
甲氨蝶呤注射液
Approval Number
国药准字HJ20233146
Approval Date
Mar 24, 2023
NMPA

Methotrexate Injection

Product Name
甲氨蝶呤注射液
Approval Number
国药准字HJ20233143
Approval Date
Mar 24, 2023
NMPA

Methotrexate Injection

Product Name
甲氨蝶呤注射液
Approval Number
国药准字HJ20233144
Approval Date
Mar 24, 2023
NMPA

Methotrexate Injection

Product Name
甲氨蝶呤注射液
Approval Number
国药准字HJ20233141
Approval Date
Mar 24, 2023
NMPA

Methotrexate Injection

Product Name
甲氨蝶呤注射液
Approval Number
国药准字HJ20233145
Approval Date
Mar 24, 2023
NMPA

Methotrexate Injection

Product Name
甲氨蝶呤注射液
Approval Number
国药准字HJ20233142
Approval Date
Mar 24, 2023
NMPA

Methotrexate Injection

Product Name
甲氨蝶呤注射液
Approval Number
国药准字HJ20233140
Approval Date
Mar 24, 2023
NMPA

Methotrexate Injection

Product Name
甲氨蝶呤注射液
Approval Number
国药准字HJ20233139
Approval Date
Mar 24, 2023
NMPA

Clinical Trials

Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials

Phase 1
11 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.